These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31162908)

  • 21. [Methanaphylaxis of urolithiasis. Part 3. The factors associated with increase in incidence of urinary stone disease. Current views on the mechanisms of stone formation].
    Saenko VS; Gazimiev MA; Pesegov SV; Alyaev YG
    Urologiia; 2019 Apr; (1):105-112. PubMed ID: 31184027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of the diuretic efficacy and tolerability of therapy with Rocchetta mineral water in patients with recurrent calcium kidney stones].
    Trinchieri A; Boccafoschi C; Chisena S; De Angelis M; Seveso M
    Arch Ital Urol Androl; 1999 Apr; 71(2):121-4. PubMed ID: 10408129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fiuggi mineral water: clinical reality and pharmaco-therapeutic attributes].
    Carmignani M; Volpe AR; Zaio A
    Ann Ig; 1997; 9(6 Suppl 1):S1-S19. PubMed ID: 9658676
    [No Abstract]   [Full Text] [Related]  

  • 24. [Interdisciplinary approach for prevention of recurrent urinary stone disease].
    Saenko VS; Pesegov SV
    Urologiia; 2020 Nov; (5):87-92. PubMed ID: 33185354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of 24-hour urine collection in high risk stone formers.
    Milose JC; Kaufman SR; Hollenbeck BK; Wolf JS; Hollingsworth JM
    J Urol; 2014 Feb; 191(2):376-80. PubMed ID: 24018242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients Attending Shared Medical Appointments for Metabolic Stone Prevention Have Decreased Stone Risk Factors.
    Jhagroo RA; Nakada SY; Penniston KL
    J Endourol; 2016 Nov; 30(11):1262-1268. PubMed ID: 27673722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An empirical study on hospital-based prevention of recurrent urinary stone disease in Germany.
    Reicherz A; Rausch P; Herout R; Noldus J; Bach P
    World J Urol; 2022 Jan; 40(1):237-242. PubMed ID: 34406436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A complementary approach to urolithiasis prevention.
    Anderson RA
    World J Urol; 2002 Nov; 20(5):294-301. PubMed ID: 12522585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The use of local vibration and ultrasound in the rehabilitation of urolithiasis patients with the "stone pathway" syndrome of the distal ureter].
    Li AA; Nesterov NI; Avilov VIa
    Vopr Kurortol Fizioter Lech Fiz Kult; 1996; (2):36-8. PubMed ID: 8928441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical Treatment and Prevention of Urinary Stone Disease.
    Spradling K; Ganesan C; Conti S
    Urol Clin North Am; 2022 May; 49(2):335-344. PubMed ID: 35428438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 24 Hour urine metabolic differences between solitary and multiple stone formers: Results of the Collaboration on Urolithiasis in Pediatrics (CUP) working group.
    Saitz TR; Mongoue-Tchokote S; Sharadin C; Giel DW; Corbett S; Kovacevic L; Bayne AP;
    J Pediatr Urol; 2017 Oct; 13(5):506.e1-506.e5. PubMed ID: 28526618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary stone disease - assessment and management.
    Macneil F; Bariol S
    Aust Fam Physician; 2011 Oct; 40(10):772-5. PubMed ID: 22003478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of mineral water containing calcium and magnesium on calcium oxalate urolithiasis risk factors.
    Rodgers AL
    Urol Int; 1997; 58(2):93-9. PubMed ID: 9096270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of stone disease.
    Porena M; Guiggi P; Micheli C
    Urol Int; 2007; 79 Suppl 1():37-46. PubMed ID: 17726351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The stone clinic effect in patients with idiopathic calcium urolithiasis.
    Hosking DH; Erickson SB; Van den Berg CJ; Wilson DM; Smith LH
    J Urol; 1983 Dec; 130(6):1115-8. PubMed ID: 6644890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of Polish health resorts in the treatment and prevention of urolithiasis].
    Modliński L
    Pol Przegl Chir; 1972 Feb; 44(2):Suppl:343-9. PubMed ID: 5020049
    [No Abstract]   [Full Text] [Related]  

  • 37. Pediatric urolithiasis--evaluation of risk factors in 95 children.
    Erbagci A; Erbagci AB; Yilmaz M; Yagci F; Tarakcioglu M; Yurtseven C; Koyluoglu O; Sarica K
    Scand J Urol Nephrol; 2003; 37(2):129-33. PubMed ID: 12745721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical studies on recurrence of urolithiasis. (2) Hypercalciuria and recurrence of urolithiasis].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Nov; 33(11):1766-71. PubMed ID: 3445858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline.
    Straub M; Strohmaier WL; Berg W; Beck B; Hoppe B; Laube N; Lahme S; Schmidt M; Hesse A; Koehrmann KU
    World J Urol; 2005 Nov; 23(5):309-23. PubMed ID: 16315051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rational prevention of calcium urolithiasis.
    Butz M
    Urol Int; 1986; 41(5):387-92. PubMed ID: 3544440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.